Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2014


COPD: Novel Therapeutics and Management

20 Oct 2014 - 21 Oct 2014 - London, UK



Bookmark and Share


SMi is proud to present its 6th annual conference on COPD taking place from the 20th - 21st October 2014 in Central London. 

With the global COPD market forecasted to reach a value of $15.6 billion by 2019, COPD 2014 comes at a perfect time to provide the industry with a niche platform for discussion and a forum to learn from key visionaries in the field of COPD. 

The latest instalment in the successful series has evolved to include topical and current sessions, such as Patient Care and The Future of COPD, as well as presenting attendees with in-depth information on exacerbation and comorbidities, ensuring a successful clinical trial design and challenges in drug development and market access. 

“Fast and cost effective development of drugs that help to improve significantly the quality of life of patients requires the intensified collaboration of industry, academia, clinical research and regulators agencies. Working in the field of biomarkers at the interface of pre-clinical and clinical research makes this an everyday requirement. The 6th COPD conference will bring together key opinion leaders from different stakeholders and will therefore foster this collaboration, especially by providing a very focused agenda.” Thomas Schlange, Senior Biomarker Expert, Bayer

KEY SPEAKERS INCLUDE:

  • Marcello Milano, Executive Global Regulatory Affairs, Chiesi
  • Thomas Schlange, Senior Biomarker Expert, Bayer
  • Mercedes Prior, Head of Global Market Access, Almirall
  • Carla Bauer, Investigator, Novartis
  • Jan-Anders Karlsson, CEO, Verona Pharma
  • Ewan Walters, Medical Director, Teva
  • Rosa Lamarca, Head of Clinical Statistics, Almirall
  • Robert Wilson, Consultant Physician Lung Division, Royal Brompton Hospital
  • Abebaw Yohannes, Reader in Physiotherapy, Manchester Metropolitan University
  • Jim & Mary Nelson, Patient, Caregiver, Representatives of COPD Foundation and EFFORTS Online Support Group

WHY ATTEND THIS EVENT:

  • Understand the regulatory aspects of COPD, both from regulatory bodies and the industry
  • Examine the current challenges to modelling exacerbations in COPD using animal models
  • Evaluate COPD and comorbidities
  • Understand the link between COPD and anxiety and depression
  • Review the challenges in clinical trial designs and in drug development
  • Discover the importance of putting the patient at the centre of everything
  • Gain insight from real life story of a lung transplant patient

To register or to download a brochure, visit http://www.smi-online.co.uk/goto/2014copd-conference37.asp

Alternatively contact Fateja Begum on +44 (0) 207 827 6184 or email fbegum@smi-online.co.uk 



Further information
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!